Drug Safety

Desmopressin: Safety Considerations in Patients with Chronic Renal Disease
pp. 553-556(4)
Authors: Sica, Domenic A.; Gehr, Todd W.B.

Use of the Dose, Time, Susceptibility (DoTS) Classification Scheme for Adverse Drug Reactions in Pharmacovigilance Planning
pp. 557-566(10)
Authors: Callréus, Torbjörn

Heart Failure Induced by Non-Cardiac Drugs
pp. 567-586(20)
Authors: Slørdal, Lars; Spigset, Olav

Second-Generation Antipsychotics: Is There Evidence for Sex Differences in Pharmacokinetic and Adverse Effect Profiles?
pp. 587-598(12)
Authors: Aichhorn, Wolfgang; Whitworth, Alexandra B.; Weiss, Elisabeth M.; Marksteiner, Josef

Clinical Safety of Inhaled Corticosteroids for Asthma in Children: An Update of Long-Term Trials
pp. 599-612(14)
Authors: Pedersen, Søren

Increase in Nonfatal Digestive Perforations and Haemorrhages Following Introduction of Selective NSAIDs: A Public Health Concern
pp. 613-620(8)
Authors: Barnard, Louise; Lavoie, Dominic; Lajeunesse, Nancy

Temporal Relationship between Use of NSAIDs, Including Selective COX-2 Inhibitors, and Cardiovascular Risk
pp. 621-632(12)
Authors: Motsko, Stephen P.; Rascati, Karen L.; Busti, Anthony J.; Wilson, James P.; Barner, Jamie C.; Lawson, Kenneth A.; Worchel, Jason

Safety of Inhalation of a 50% Nitrous Oxide/Oxygen Premix: A Prospective Survey of 35 828 Administrations
pp. 633-640(8)
Authors: Onody, Peter; Gil, Pascal; Hennequin, Martine

A Survey of the Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting by Clinicians in Eastern India
pp. 641-642(2)
Authors: Chatterjee, Suparna; Lyle, Nazmun; Ghosh, Souvik